Albert P. Hirdt D.O. P.C. is a clinical research site located in New Paltz, New York, United States 12561.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
Albert P. Hirdt D.O. P.C. has participated in 1 clinical trials.
Therapeutic areas: Systemic Mast Cell Activation, KIT D816V Mutation.
Sponsors: Blueprint Medicines Corporation.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Albert P. Hirdt D.O. P.C. has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Albert P. Hirdt D.O. P.C. has 1 clinical trials on record. Their work covers Systemic Mast Cell Activation, KIT D816V Mutation.
Albert P. Hirdt D.O. P.C. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.